Medicaid and CHIP Access to Prescription Digital Therapeutics Act

Hozzl · 2024-03-13T02:22:53Z

Explore the details of Senate Bill 5238 Medicaid and CHIP Access to Prescription Digital Therapeutics Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/13/2024, 2:22 AM

Congressional Summary of S 5238

Medicaid and CHIP Access to Prescription Digital Therapeutics Act

This bill requires the Centers for Medicare & Medicaid Services to issue guidance for states on coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions) under Medicaid and the Children's Health Insurance Program (CHIP).

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 5238

Bill S 5238 is currently in the status of Bill Introduced since December 12, 2022. Bill S 5238 was introduced during Congress 117 and was introduced to the Senate on December 12, 2022. Bill S 5238's most recent activity was Read twice and referred to the Committee on Finance. as of December 12, 2022

Bipartisan Support of Bill S 5238

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 5238

Primary Policy Focus

Health

Alternate Title(s) of Bill S 5238

Medicaid and CHIP Access to Prescription Digital Therapeutics Act

A bill to require the Administrator of the Centers for Medicare & Medicaid Services to provide guidance regarding coverage of prescription digital therapeutics under Medicaid and the State Children's Health Insurance Program.